NEUROGENE INC (NGNE)
(Delayed Data from NSDQ)
$32.11 USD
+0.62 (1.97%)
Updated May 24, 2024 03:59 PM ET
After-Market: $31.89 -0.22 (-0.69%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -1.02 |
EPS Last Quarter | -1.00 |
Last EPS Surprise | 2.91% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.15 |
Next Year | -4.07 |
EPS (TTM) | -11.24 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.02 | -1.06 | -4.15 | -4.07 |
# of Estimates | 5 | 4 | 5 | 5 |
Most Recent Consensus | -0.96 | -0.97 | -3.92 | -4.11 |
High Estimate | -0.89 | -0.90 | -3.69 | -3.17 |
Low Estimate | -1.14 | -1.18 | -4.57 | -5.17 |
Year ago EPS | -0.80 | -1.64 | NA | -4.15 |
Year over Year Growth Est. | -27.50% | 35.37% | NA | 1.98% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 2 | 3 | 4 |
Down Last 60 Days | 2 | 2 | 3 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.02 | -1.06 | -4.15 | -4.07 |
7 Days Ago | -1.02 | -1.06 | -4.15 | -4.07 |
30 Days Ago | -0.99 | -1.03 | -3.78 | -3.42 |
60 Days Ago | -0.99 | -1.03 | -3.74 | -3.77 |
90 Days Ago | -0.90 | -0.95 | -3.59 | -3.33 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.02 | -1.06 | -4.15 | -4.07 |
Zacks Consensus Estimate | -1.02 | -1.06 | -4.15 | -4.07 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.00 | NA | -1.64 | -0.80 | NA |
Estimate | -1.03 | NA | -3.20 | -3.00 | NA |
Difference | 0.03 | NA | 1.56 | 2.20 | 1.26 |
Surprise | 2.91% | NA | 48.75% | 73.33% | 41.66% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more